Holen Sie sich die Stockscreener-App
2.42
3.97%
-0.10
Schlusskurs vom Vortag:
$2.52
Offen:
$2.45
24-Stunden-Volumen:
14,456
Relative Volume:
0.63
Marktkapitalisierung:
$171.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.97M
KGV:
-2.4494
EPS:
-0.988
Netto-Cashflow:
$-1.18M
1W Leistung:
-25.54%
1M Leistung:
-52.17%
6M Leistung:
-78.65%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.3783
$2.655
1-Wochen-Bereich:
$2.3783
$3.5499
52-Wochen-Spanne:
$2.3783
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
2.42 | 171.41M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Yd Bio Ltd Aktie (YDES) Neueste Nachrichten
BRZHR Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
YD Bio Ord Shs (YDES) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
YD Bio Ord Shs (YDES) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
YD Bio Ord Shs (YDES) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
YD Bio Ord Shs (YDES) Institutional Confidence - TradingKey
YD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
YD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
YD Bio Ord Shs (YDES) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
YD Bio Ord Shs (YDES) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
YD Bio Ord Shs (YDES) Valuation: PE, PB & Fair Value Analysis - TradingKey
Morning Market Movers: SLBT, SCLX, TDIC, CRE See Big Swings - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] YD Bio Ltd SEC Filing - Stock Titan
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview - Yahoo Finance
YD Bio Stock Is Falling Again: The SEC Filing Behind the Slide - Bez Kabli
iGan Partners Invests in Adenocyte Ltd to Advance the Early Detection of Pancreatic Cancer - Yahoo Finance
YD Bio (NASDAQ: YDES) prospectus lists 58.6M resale shares, 11.4M exercisable - Stock Titan
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX) - Yahoo Finance
Registrar Corp and U.S. Commercial Service Strengthen Partnership to Support Australian Companies Expanding into the U.S. - Yahoo Finance
Yourgene Health Launches Insight DPYD Assay - Yahoo Finance
Affiliated (MGRE) Steady at $$24.02 — Awaiting Next Catalyst 2026-05-13Rip Sell Trade - The Legal Advocate
YD Bio Limited Ordinary Shares Stock Forecast Summary - Meyka
Autoliv posts upbeat Q1 results, joins United Airlines, Royal Caribbean Cruises and other big stocks moving higher on Friday - MSN
YD Bio Limited Reports Full Year 2025 Financial Results - ChartMill
YD Bio Limited Reports Financial Results for Full Year 2025, Achieves 17% Revenue Growth and Strategic Advances in Healthcare Innovations - Quiver Quantitative
YD Bio 2025 Loss/Shr 12c >YDES - Moomoo
After a $13.9M equity raise, YD Bio enters 2026 with $6M cash - Stock Titan
Going concern warning tops YD Bio (NASDAQ: YDES) 20-F risk disclosures - Stock Titan
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026 - Yahoo Finance
New LowStock ScreenerSnapshot - Finviz
Immuneering Corp (IMRX) Stock Price, Quote, News & History - Benzinga
CMMB (Chemomab Therapeutics Ltd. American Depositary Share) posts narrower Q4 2025 loss than estimates, while shares dip modestly.Community Trade Ideas - Xã Thanh Hà
What is happening with Elbit Systems (ESLT) stock today (Smart Money Active) 2026-04-20High Interest Stocks - Cổng thông tin điện tử tỉnh Lào Cai
[Form 3/A] YD Bio Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Shao Ta Lu Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday - Sahm
Man Edmund Hen Net Worth (2026) - GuruFocus
Bo Xiang Zhang Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Movi - Benzinga
GFL ENVIRONMENTAL INC. (GFL) - MSN
How does macroeconomics affect YD Bio (YDES) Stock | Price at $5.97, Down 4.57%Portfolio Management - newser.com
Is YD Bio (YDESW) Stock slowing down | Price at $0.58, Down 10.08%Market Hype Signals - Newser
Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness - Yahoo Finance
YDES Technical Analysis & Stock Price Forecast - Intellectia AI
YDES SEC FilingsYD Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
CRVL Stock Analysis: CorVel Corp. notches 1.6 pct daily gain near 54 key support - The Legal Advocate
YD Bio (YDES) director receives $60,000 RSU grant and 2,081 shares - Stock Titan
Director at YD Bio (YDES) receives $60K RSU equity award - Stock Titan
YD Bio (NASDAQ: YDES) director Lu Shao-Ta files initial Form 3 - Stock Titan
Director Chang Kochi logs initial insider status at YD Bio Ltd (YDES) - Stock Titan
YD Bio launches telehealth platform for cancer detection By Investing.com - Investing.com South Africa
Finanzdaten der Yd Bio Ltd-Aktie (YDES)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):